Protein services and sample-preparation firm Protea Biosciences this week announced it has in-licensed biomarkers discovered by Johns Hopkins University researchers that it will use to develop a tool to capture proteins implicated in heart disease.

The proteins, which are bound to human serum albumin and the albumin molecule itself, were discovered by Jenny Van Eyk and her team at JHU, where she is a professor of medicine and director of the Johns Hopkins NHLBI Proteomics Center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.